Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Passweg

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|November 21, 2012
Treatment and hematopoietic SCT in aplastic anemiaJ R Passweg, M Aljurf
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Molecular diagnosis/molecular therapy]H Moch, J R Passweg
Revue Medicale Suisse|May 30, 2009
[Neuropathy associated with monoclonal gammopathy (dysglobulinemia)]P H Lalive, J R Passweg, T Kuntzer
Hematology/Oncology Clinics of North America|April 2, 1998
Related donor bone marrow transplantation for chronic myelogenous leukemiaJ R Passweg, P A Rowlings, M M Horowitz
Bone Marrow Transplantation|May 1, 1996
Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant RegistryM M Horowitz, P A Rowlings, J R Passweg
Bone Marrow Transplantation|November 25, 2010
Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisalA Fontanet, Y Chalandon, E Roosnek, et al.
Bone Marrow Transplantation|January 18, 2005
Use of natural killer cells in hematopoetic stem cell transplantationJ R Passweg, M Stern, U Koehl, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 23, 2015
[Bilateral Optic Disc Swelling, Vitreous Haemorrhage and Roth's Spots in Chronic Myeloid Leukemia]S P Rothenbuehler, A M Palmowski-Wolfe, J R Passweg, et al.
Annals of Hematology|July 20, 2000
Myeloproliferative disorders: complications, survival and causes of deathS Brodmann, J R Passweg, A Gratwohl, et al.
ESMO Open|January 10, 2021
Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patientsS I Rothschild, R Nachbur, N Herzog, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|November 21, 2012
Treatment and hematopoietic SCT in aplastic anemiaJ R Passweg, M Aljurf
Therapeutische Umschau. Revue Therapeutique|May 13, 2006
[Molecular diagnosis/molecular therapy]H Moch, J R Passweg
Revue Medicale Suisse|May 30, 2009
[Neuropathy associated with monoclonal gammopathy (dysglobulinemia)]P H Lalive, J R Passweg, T Kuntzer
Hematology/Oncology Clinics of North America|April 2, 1998
Related donor bone marrow transplantation for chronic myelogenous leukemiaJ R Passweg, P A Rowlings, M M Horowitz
Bone Marrow Transplantation|May 1, 1996
Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant RegistryM M Horowitz, P A Rowlings, J R Passweg
Bone Marrow Transplantation|November 25, 2010
Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisalA Fontanet, Y Chalandon, E Roosnek, et al.
Bone Marrow Transplantation|January 18, 2005
Use of natural killer cells in hematopoetic stem cell transplantationJ R Passweg, M Stern, U Koehl, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 23, 2015
[Bilateral Optic Disc Swelling, Vitreous Haemorrhage and Roth's Spots in Chronic Myeloid Leukemia]S P Rothenbuehler, A M Palmowski-Wolfe, J R Passweg, et al.
Annals of Hematology|July 20, 2000
Myeloproliferative disorders: complications, survival and causes of deathS Brodmann, J R Passweg, A Gratwohl, et al.
ESMO Open|January 10, 2021
Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patientsS I Rothschild, R Nachbur, N Herzog, et al.
Pageof 8